NORMOZIDE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Normozide, and what generic alternatives are available?
Normozide is a drug marketed by Schering and is included in one NDA.
The generic ingredient in NORMOZIDE is hydrochlorothiazide; labetalol hydrochloride. There are thirty-two drug master file entries for this compound. Additional details are available on the hydrochlorothiazide; labetalol hydrochloride profile page.
Summary for NORMOZIDE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 72 |
Formulation / Manufacturing: | see details |
DailyMed Link: | NORMOZIDE at DailyMed |
Anatomical Therapeutic Chemical (ATC) Classes for NORMOZIDE
US Patents and Regulatory Information for NORMOZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-001 | Apr 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-004 | Apr 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-002 | Apr 6, 1987 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for NORMOZIDE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-002 | Apr 6, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-002 | Apr 6, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
Schering | NORMOZIDE | hydrochlorothiazide; labetalol hydrochloride | TABLET;ORAL | 019046-003 | Apr 6, 1987 | ⤷ Try a Trial | ⤷ Try a Trial |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for NORMOZIDE
See the table below for patents covering NORMOZIDE around the world.
Country | Patent Number | Title | Estimated Expiration |
---|---|---|---|
Czechoslovakia | 167874 | ⤷ Try a Trial | |
Yugoslavia | 86768 | ⤷ Try a Trial | |
Malaysia | 7400003 | PHENYLAMINOETHANOL DERIVATIVES | ⤷ Try a Trial |
>Country | >Patent Number | >Title | >Estimated Expiration |
Supplementary Protection Certificates for NORMOZIDE
Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
---|---|---|---|---|
0454511 | SPC/GB99/008 | United Kingdom | ⤷ Try a Trial | PRODUCT NAME: 2-N-BUTYL-4-SPIROCYCLOPENTANE-1-((2'-(TETRAZOL-5-YL)BIPHENYL-4-YL)METHYL)-2-IMIDAZOLIN-5-ONE)(GENERIC NAME IRBESARTAN) OPTIONALLY IN THE FORM OF ONE OF ITS SALTS AND HYDROCHLOROTHIAZIDE; REGISTERED: UK EU/1/98/086/001 19981015; UK EU/1/98/086/002 19981015; UK EU/1/98/086/003 19981015; UK EU/1/98/086/004 19981015; UK EU/1/98/086/005 19981015; UK EU/1/98/086/006 19981015 |
0443983 | C00443983/03 | Switzerland | ⤷ Try a Trial | PRODUCT NAME: VALSARTAN + AMLODIPINE + HYDROCHLOROTHIAZIDE; REGISTRATION NUMBER/DATE: SWISSMEDIC 59407 16.09.2009 |
0502314 | C300095 | Netherlands | ⤷ Try a Trial | PRODCUT NAME: TELMISARTAN, DESGEWENST IN DE VORM VAN EEN FYSIOLOGISCH VERDRAAGBAAR ZOUT, EN HYDROCHLOROTHIAZIDE; REGISTRATION NO/DATE: EU/1/02/213/001-010 20020419 |
>Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |